10.6084/m9.figshare.c.3623249_D3.v1
Eduardo Castañón
Eduardo
Castañón
Christian Rolfo
Christian
Rolfo
David Viñal
David
Viñal
Inés López
Inés
López
Juan Fusco
Juan
Fusco
Marta Santisteban
Marta
Santisteban
Patricia Martin
Patricia
Martin
Leire Zubiri
Leire
Zubiri
José Echeveste
José
Echeveste
Ignacio Gil-Bazo
Ignacio
Gil-Bazo
Additional file 4: of Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis
Springer Nature
2015
Liver metastasis
Non-small cell lung cancer (NSCLC)
Epidermal growth factor receptor (EGFR)
EGFR tyrosin-kinase inhibitors
Prognosis
2015-08-07 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_4_of_Impact_of_epidermal_growth_factor_receptor_EGFR_activating_mutations_and_their_targeted_treatment_in_the_prognosis_of_stage_IV_non-small_cell_lung_cancer_NSCLC_patients_harboring_liver_metastasis/4400564
Table S4. Univariate Regression Model for predicting OS (overall survival) in our clinical series.